[1]
Kanani, P.R. and Pillai, A. 2020. A comparative study of effectiveness, safety and cost effectiveness of olanzapine, risperidone and aripiprazole therapy in schizophrenia. International Journal of Basic & Clinical Pharmacology. 9, 5 (Apr. 2020), 786–791. DOI:https://doi.org/10.18203/2319-2003.ijbcp20201759.